We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

NicOx Signs Agreement for the Commercial Manufacture of Naproxcinod Drug Substance

News   Mar 21, 2008

 
NicOx Signs Agreement for the Commercial Manufacture of Naproxcinod Drug Substance
 
 
 

RELATED ARTICLES

Simulations Enable 'Choose-your-own-Adventure' Stereochemistry

News

Stereochemistry is a science of reflection. Two chemical molecules with the same composition and structure, but with one as the mirror image of the other, can produce wildly varying effects. But University of Utah chemist Matt Sigman has been developing a way to get a better grasp on this tricky field of chemistry.

READ MORE

Plug-and-Play Technology Automates Chemical Synthesis

News

MIT researchers have now developed an automated chemical synthesis system that can take over many of the more tedious aspects of chemical experimentation, freeing up chemists to spend more time on the more analytical and creative aspects of their research.

READ MORE

Scientists Develop New Drug Treatment for TB

News

Scientists at The University of Manchester have developed the first non-antibiotic drug to successfully treat tuberculosis in animals. The team hope the compound –developed after 10 years of painstaking research will be trialed on humans within three to four years.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE